Discovery of potential ALK inhibitors by virtual screening approach.

Abstract

Crizotinib is an anticancer drug used for the treatment of non-small cell lung cancer. Evidences available suggest that there is a development of an acquired resistance against crizotinib action due to the emergence of several mutations in the ALK gene. It is therefore necessary to develop potent anti-cancer drugs for the treatment of crizotinib resistance… (More)
DOI: 10.1007/s13205-015-0336-z

Topics

Cite this paper

@article{Kumar2016DiscoveryOP, title={Discovery of potential ALK inhibitors by virtual screening approach.}, author={Anish Kumar and V. Shanthi and Ramanathan Karuppasamy}, journal={3 Biotech}, year={2016}, volume={6 1}, pages={21} }